Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Variant Organic Cation Transporter 2 (Oct2)-T201m Contribute to Changes in Insulin Resistance in Patients With Type 2 Diabetes Treated With Metformin Publisher Pubmed



Kashi Z1 ; Masoumi P2 ; Mahrooz A2, 3 ; Hashemisoteh MB2, 3 ; Bahar A1 ; Alizadeh A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Diabetes Research Center, Imam Teaching Hospital, Mazandaran University of Medical Sciences, Sari, Iran
  2. 2. Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  3. 3. Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran
  4. 4. Department of Epidemiology and Biostatistics, Faculty of Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Diabetes Research and Clinical Practice Published:2015


Abstract

Aims: Insulin resistance is characterized by impaired biological response of peripheral tissues to the metabolic effects of insulin. Organic cation transporter 2 (OCT2) is responsible for 80% metformin clearance. Limited information is available on the potential relationship between genetic variants of OCT2 and insulin resistance. In this study, we examined the role of OCT2-T201M (602 C>T) variant in insulin resistance in patients with type 2 diabetes (T2D) who were treated with metformin. Methods: Serum concentrations of insulin and C-peptide were assessed using ELISA. Homeostasis model assessment for insulin resistance (HOMA-IR) and HOMA for beta cell function (HOMA-BCF) were determined. PCR-based restriction fragment length polymorphism was used to genotype the OCT2-T201M variant. Results: Patients with minor alleles had higher HbA1c concentrations (p = 0.019), fasting glucose levels (p = 0.023), HOMA-IR (p = 0.03), and HOMA-BCF (p = 0.26) than patients with common alleles. Multivariate analysis identified a significant association between the variables OCT2-T201M and gender, with HOMA-IR and HOMA-BCF (Wilks' λ = 0.549, F = 12.71, p < 0.001 for OCT2-T201M and Wilks' λ = 0.369, F = 26.46, p < 0.001 for gender. Changes in HOMA-BCF were inversely correlated with changes in fasting glucose levels (r = -0.412, p = 0.008) and HbA1c (r = -0.257, p = 0.114). Conclusions: Our findings suggest that the loss-of-function variant OCT2-T201M (rs145450955) contribute to changes in insulin resistance and beta cell activity in patients with T2D treated with metformin. Moreover, gender as an independent variable has a significant relationship with HOMA-BCF. © 2015 Elsevier Ireland Ltd.